
Opinion|Videos|November 26, 2024
Utilizing Antibiotics in Treatment of C Difficile
Author(s)Paul Feuerstadt, MD, FACG, AGAF
Key Takeaways
- Antibiotics can disrupt gut microbiota, leading to potential recurrences of Clostridioides difficile infections (CDI).
- New therapies like fecal microbiota transplantation (FMT) and monoclonal antibodies aim to restore healthy gut flora and provide targeted immune support.
The panelist discusses how antibiotics are paradoxically both the primary treatment for Clostridioides difficile infections and a major risk factor for recurrence since they disrupt the protective gut microbiome, which led to the development of alternative therapies like fecal microbiota transplantation to restore microbial balance and prevent reinfection.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What is the role of antibiotics in the treatment of recurrent C difficile infections?
- Why was it necessary to develop new therapies beyond antibiotics?
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Trump Announces Timeline for 100% Generic Drug Tariffs Beginning in 2028, 200% in 2029
2
Fifth Death Confirmed in NYC Legionnaires' Outbreak
3
Obesity, Insulin Resistance, and the Silent Progression of MASH: A Hepatologist's Perspective
4
Pirtobrutinib Plus Venetoclax-Rituximab Cuts CLL Progression 45%
5






